Validation of Walking and Remembering Test

A Study to Assess The Balance Using Remote Access Method - Walking and Remembering Test Validation

In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. The second evaluation will be carried out using a remote method. From the participants;

• He/she will first be asked to walk freely within a line that is 8 meters long and 19 cm wide. Later;
• He will be asked to walk once at average speed and three times as fast as possible in the same line. Later;
• The participant is given a Counting Test. This test includes number sequences from 4 digits to 9 digits. Participants are told these number strings and asked to repeat them with the same speed and tone of voice. The longest sequence of numbers is recorded. Later;
• The participant is walked on the same line again and asked to repeat the longest number sequence he remembers and the test is completed. Cognitive performance with the counting test reflects walking speed during 4 walks, and the number of incorrect steps reflects walking performance.

Study Overview

• Status: Completed
• Conditions: Healthy Individuals
• Intervention / Treatment: Other: Walking and Remembering Test

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • İstanbul, Turkey, 34840
    • Marmara University, Department of Physiotherapy and Rehabilitation, Biomechanics and Performance Analysis Laboratory

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Having any known psychological, vestibular and neurological diseases,
• No major or minor hip, knee or ankle injuries,
• Not showing osteoarticular or muscle traumas that prevent upright posture and ambulation,
• Not taking medications that affect posture, such as vestibular apparatus sedatives, antidepressants or anxiolytics,
• Not complaining of dizziness or vertigo,
• Being between the ages of 18-30.

Exclusion Criteria:

• Individuals with untreated visual impairment,
• Epilepsy, postural dizziness or hypotension,
• Individuals with dependent ambulation,
• Individuals with any disease that affects balance,
• Those with cancer or fibromyalgia.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Walking and Remembering Group; Only Walking and Remembering Test will be applied to the group.	Other: Walking and Remembering Test; Only Walking and Remembering Test will be applied to the group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Walking and Remembering Test (WART)	WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.	Baseline of the study (Face-to-Face)
Walking and Remembering Test (WART)	WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.	First day after the Baseline Assessment (Remote Assessment)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Demographic Data Form	This form was created by researchers and it consist of personal informations such as gender, dominant extremity, history of sport, age, body mass index	Baseline of the study

Collaborators and Investigators

• Sponsor: Emre Şenocak
• Investigators: Study Chair: Aysel Yildiz Ozer, Professor, Marmara University; Study Chair: Semra Oğuz, Associate Professor, Marmara University; Study Chair: Gökçe Kartal, MSc, Marmara University

Study record dates

Study Major Dates

• Study Start (Actual): July 29, 2024
• Primary Completion (Actual): February 28, 2025
• Study Completion (Actual): February 28, 2025

Study Registration Dates

• First Submitted: August 29, 2024
• First Submitted That Met QC Criteria: August 29, 2024
• First Posted (Actual): August 30, 2024

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 4, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Keywords: Healthy; Validity; Tele-assessment; Walking and Remembering Test
• Other Study ID Numbers: 25.07.2024/112

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No